Home |
SiteMap | Welcome to Ourchemical.
Sign In |
Join Free
194240-75-0 Information
Indian drugs in the 194240-75-0 United States to apply approved the 194240-75-0 increase in|||in March 2003 to June 2003 of four months, 25% of the 194240-75-0 Indian pharmaceutical companies accounted for U.S. FDA-approved drugs of the 194240-75-0 master files (DMFs). about 148 DMFs in the 194240-75-0 declaration to the 194240-75-0 British FDA, 34 DMFs receiving approval from the 194240-75-0 Indian companies. This shows that is actively turning India from a 194240-75-0 disorderly market to orderly market in the United States. Experts believe that this is mainly because India pharmaceutical companies with significant cost advantages in the production of generic drugs, and to meet the U.S. FDA management needs. Indian domestic pharmaceutical market is highly competitive, coupled with India after 2005 will be implemented in the product patent law, the smaller the Indian pharmaceutical The company will face a 194240-75-0 crisis of survival. These small companies are turning their focus shifted to the foreign markets, and by acting the way of the companys raw material base of the international generic drugs to relieve the pressure to survive.Dictionary